Glaucoma patients who take medication for the condition appear to have a reduced likelihood of death, according to a report in the February issue of Archives of Ophthalmology, one of the JAMA/Archives ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma-related ocular surface disease is a significant and often underdiagnosed ocular comorbidity that can ...

Prices of branded glaucoma medications increased in the U.S. over the past 7 years, according to a study published in the Journal of Glaucoma. “Reducing IOP is the only proven method to treat glaucoma ...

In matched cohorts of more than 41,000 patients each, use of tirzepatide was linked to a significantly reduced risk of primary open-angle glaucoma compared with selective GLP-1 receptor agonists (risk ...

Smith, MD, of Glaucoma Associates of Texas, in Dallas, sat down with the Eye Care Network to reflect on how glaucoma care ...

Expert Rev Ophthalmol. 2010;5(3):405-412. Benzalkonium chloride is the most common preservative in antiglaucoma preparations and its toxic effects depend on the dose and duration of exposure. Chronic ...

Philadelphia, December 28, 2007 – In the United States, the management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...

Glaucoma, the silent thief of sight, damages the optic nerve without early symptoms, leading to irreversible vision loss.

OT dives into a key topic in the education programme at 100% Optical 2026. This week: Sana Hamid shares insight into her ...

From artificial intelligence to home monitoring, Joel Schuman, MD, of Wills Eye Hospital, explores the innovations that could ...